Development and Validation of a Nomogram to Predict the Risk of Special Uterine Leiomyoma Pathological Types or Leiomyosarcoma in Postmenopausal Women: A Retrospective Study

References

• Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science. 2005;308(5728):1589–1592. doi:10.1126/science.1112063
   PubMed Web of Science ®Google Scholar
• Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet off Organ Int Fed Gynaecol Obstet. 2020;149(1):3–9. doi:10.1002/ijgo.13102
   PubMed Web of Science ®Google Scholar
• Wright JD, Herzog TJ, Tsui J, et al. Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstetrics Gynecol. 2013;122(2 Pt 1):233–241. doi:10.1097/AOG.0b013e318299a6cf
   PubMed Web of Science ®Google Scholar
• Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Epidemiology and risk factors of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2018;46:3–11. doi:10.1016/j.bpobgyn.2017.09.004
   PubMed Web of Science ®Google Scholar
• Templeman C, Marshall SF, Clarke CA, et al. Risk factors for surgically removed fibroids in a large cohort of teachers. Fertil Sterility. 2009;92(4):1436–1446. doi:10.1016/j.fertnstert.2008.08.074
   PubMed Web of Science ®Google Scholar
• Ghosh S, Naftalin J, Imrie R, Hoo WL. Natural history of uterine fibroids: a radiological perspective. Current Obstet Gynecol Rep. 2018;7(3):117–121. doi:10.1007/s13669-018-0243-5
   PubMedGoogle Scholar
• Ciarmela P, Ciavattini A, Giannubilo SR, et al. Management of leiomyomas in perimenopausal women. Maturitas. 2014;78(3):168–173. doi:10.1016/j.maturitas.2014.04.011
   PubMed Web of Science ®Google Scholar
• Peddada SD, Laughlin SK, Miner K, et al. Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci USA. 2008;105(50):19887–19892. doi:10.1073/pnas.0808188105
   PubMed Web of Science ®Google Scholar
• Dayal S, Kumar A, Verma A. Clinicopathologic correlation of leiomyoma with clinical findings and secondary changes in a rural population of north India. Am J Clin Pathol. 2014;141(2):275–279. doi:10.1309/AJCPSLMZ1TOC4JCF
   PubMed Web of Science ®Google Scholar
• Robboy SJ, Bentley RC, Butnor K, Anderson MC. Pathology and pathophysiology of uterine smooth-muscle tumors. Environ Health Persp. 2000;108(5):779–784. doi:10.1289/ehp.00108s5779
   PubMedGoogle Scholar
• Böcker W. WHO-Klassifikation der Tumoren der Mamma und des weiblichen Genitale: pathologie und Genetik [WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics]. Verhandl Der Deut Gesellsch Fur Pathol. 2002;86:116–119. German.
   PubMedGoogle Scholar
• Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594. doi:10.1136/bmj.g7594
   PubMed Web of Science ®Google Scholar
• Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thora Oncol. 2010;5(9):1315–1316. doi:10.1097/JTO.0b013e3181ec173d
   PubMed Web of Science ®Google Scholar
• Gadducci A, Zannoni GF. Uterine smooth muscle tumors of unknown malignant potential: a challenging question. Gynecol Oncol. 2019;154(3):631–637. doi:10.1016/j.ygyno.2019.07.002
   PubMed Web of Science ®Google Scholar
• Kim K, Kim S, Ahn T, et al. A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis. BMC Cancer. 2023;23(1):1215. doi:10.1186/s12885-023-11394-0
   PubMed Web of Science ®Google Scholar
• Zhou Y, Lu Q, Chen Z, Lu P. A prediction nomogram for recurrent retinal detachment. Risk Manag Healthc Policy. 2023;16:479–488. doi:10.2147/RMHP.S403136
   PubMed Web of Science ®Google Scholar
• Ao X, Zhang L, Huang L, Chen X, Geng L, Xu X. Development of a nomogram model for predicting the risk of in-hospital death in patients with acute kidney injury. Risk Manag Healthc Policy. 2021;14:4457–4468. doi:10.2147/RMHP.S321399
   PubMed Web of Science ®Google Scholar
• Cheng Q, Sun Z, Zhao G, Xie L. Nomogram for the individualized prediction of survival among patients with H7N9 infection. Risk Manag Healthc Policy. 2020;13:255–269. doi:10.2147/RMHP.S242168
   PubMed Web of Science ®Google Scholar
• Ma Y, Li L, Yu L, et al. Optimization of diagnosis-related groups for 14,246 patients with uterine leiomyoma in a single center in western china using a machine learning model. Risk Manag Healthc Policy. 2024;17:473–485. doi:10.2147/RMHP.S442502
   PubMed Web of Science ®Google Scholar
• Van Calster B, Wynants L, Verbeek JFM, et al. Reporting and interpreting decision curve analysis: a guide for investigators. Europ urol. 2018;74(6):796–804. doi:10.1016/j.eururo.2018.08.038
   PubMed Web of Science ®Google Scholar
• Clarke MA, Long BJ, Del Mar Morillo A, Arbyn M, Bakkum-Gamez JN, Wentzensen N. Association of endometrial cancer risk with postmenopausal bleeding in women: a systematic review and meta-analysis. JAMA Intern Med. 2018;178(9):1210–1222. doi:10.1001/jamainternmed.2018.2820
   PubMed Web of Science ®Google Scholar
• Sebastian A, Neerudu SR, Rebekah G, et al. Risk factors for endometrial carcinoma in women with postmenopausal bleeding. J Obstet Gynaecol India. 2021;71(4):417–423. doi:10.1007/s13224-021-01464-3
   PubMed Web of Science ®Google Scholar
• Harrison JE, Weber S, Jakob R, Chute CG. ICD-11: an international classification of diseases for the twenty-first century. BMC Med Inf Decis Making. 2021;21(Suppl 6):206. doi:10.1186/s12911-021-01534-6
   PubMed Web of Science ®Google Scholar
• Zhang F, Liu Y, Quan Q, Meng Y, Mu X. Diagnostic Value of Preoperative CA125, LDH and HE4 for Leiomyosarcoma of the Female Reproductive System. Cancer Manage Res. 2021;13:4657–4664. doi:10.2147/CMAR.S302223
   PubMed Web of Science ®Google Scholar
• Korkmaz V, Ozkaya E, Özer Kadife S, Kara F, Kucukozkan T. Investigation of cardiovascular disease risk in women with uterine leiomyomas. Irish J Med Sci. 2016;185(3):689–693. doi:10.1007/s11845-015-1343-0
   PubMed Web of Science ®Google Scholar
• Duan Y, Peng Y, Shi X, et al. Correlation between platelet-lymphocyte ratio and neutrophil-lymphocyte ratio in patients with uterine leiomyoma: a cross-sectional study. J Oncol. 2022;2022:3257887. doi:10.1155/2022/3257887
   PubMed Web of Science ®Google Scholar
• Cho HY, Kim K, Kim YB, No JH. Differential diagnosis between uterine sarcoma and leiomyoma using preoperative clinical characteristics. J Obstet Gynaecol Res. 2016;42(3):313–318. doi:10.1111/jog.12915
   PubMed Web of Science ®Google Scholar
• Nguyen PN, Nguyen VT. Endometrial thickness and uterine artery Doppler parameters as soft markers for prediction of endometrial cancer in postmenopausal bleeding women: a cross-sectional study at tertiary referral hospitals from Vietnam. Obstet Gynecol Sci. 2022;65(5):430–440. doi:10.5468/ogs.22053
   PubMedGoogle Scholar
• Nguyen PN, Nguyen VT. Additional value of Doppler ultrasound to B-mode ultrasound in assessing for uterine intracavitary pathologies among perimenopausal and postmenopausal bleeding women: a multicentre prospective observational study inVietnam. J Ultrasound. 2023;26(2):459–469. doi:10.1007/s40477-022-00732-w
   PubMed Web of Science ®Google Scholar
• Riley RD, Ensor J, Snell KIE, et al. Calculating the sample size required for developing a clinical prediction model. BMJ. 2020;368:m441. doi:10.1136/bmj.m441
   PubMed Web of Science ®Google Scholar
• Kudo S, Fujimoto M, Sato T, Nagano A. Determination of the optimal number of linked rigid-bodies of the trunk during walking and running based on Akaike’s information criterion. Gait Posture. 2020;77:264–268. doi:10.1016/j.gaitpost.2020.02.009
   PubMed Web of Science ®Google Scholar
• Yarwood RL, Arroyo E. Cystic degeneration of a uterine leiomyoma masquerading as a postmenopausal ovarian cyst. A case report. J Reprod Med. 1999;44(7):649–652.
   PubMed Web of Science ®Google Scholar
• Shrestha R, Khanal R, Aryal MR, et al. Fibroid degeneration in a postmenopausal woman presenting as an acute abdomen. J Comm Hospital Inter Med Persp. 2015;5(1):25917. doi:10.3402/jchimp.v5.25917
   PubMedGoogle Scholar
• Okamoto T, Koshiyama M, Yamamoto K. Rapidly growing leiomyoma in a postmenopausal woman. J Obstet Gynaecol Res. 2004;30(4):316–318. doi:10.1111/j.1447-0756.2004.00200.x
   PubMed Web of Science ®Google Scholar
• Tanioka S, Asano R, Wakabayashi R, Hayashi H, Shigeta H. Possible significance of degeneration and decreased expression of progesterone receptor in postmenopausal uterine leiomyoma. BMC Women’s Health. 2022;22(1):346. doi:10.1186/s12905-022-01924-6
   PubMed Web of Science ®Google Scholar
• Oduyebo T, Hinchcliff E, Meserve EE, et al. Risk factors for occult uterine sarcoma among women undergoing minimally invasive gynecologic surgery. J Minim Invas Gynecol. 2016;23(1):34–39. doi:10.1016/j.jmig.2015.07.017
   PubMed Web of Science ®Google Scholar
• Chen I, Firth B, Hopkins L, Bougie O, Xie RH, Singh S. Clinical Characteristics Differentiating Uterine Sarcoma and Fibroids. JSLS. 2018;22(1):e2017.00066. doi:10.4293/JSLS.2017.00066
   Web of Science ®Google Scholar
• Medeiros LR, Rosa DD, da Rosa MI, Bozzetti MC. Accuracy of CA 125 in the diagnosis of ovarian tumors: a quantitative systematic review. Eur J Obstet Gynecol Reprod Biol. 2009;142(2):99–105. doi:10.1016/j.ejogrb.2008.08.011
   PubMed Web of Science ®Google Scholar
• Jacobs I, Bast RC. The CA 125 tumour-associated antigen: a review of the literature. Human Reproduct. 1989;4(1):1–12. doi:10.1093/oxfordjournals.humrep.a136832
   PubMed Web of Science ®Google Scholar
• Juang CM, Yen MS, Horng HC, Twu NF, Yu HC, Hsu WL. Potential role of preoperative serum CA125 for the differential diagnosis between uterine leiomyoma and uterine leiomyosarcoma. Eu J Gynaecol Oncol. 2006;27(4):370–374.
   PubMed Web of Science ®Google Scholar
• Kim HS, Han KH, Chung HH, et al. Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison. Europ J Surg Oncol. 2010;36(7):691–698. doi:10.1016/j.ejso.2010.05.004
   PubMed Web of Science ®Google Scholar
• Dingiloglu BS, Gungor T, Ozdal B, Cavkaytar S, Bilge U, Mollamahmutoglu L. Serum leptin levels in women with uterine leiomyomas. Taiwanese J Obstetrics Gynecol. 2007;46(1):33–37. doi:10.1016/S1028-4559(08)60103-5
   PubMedGoogle Scholar
• Dawood MY, Khan-Dawood FS. Plasma insulin-like growth factor-I, CA-125, estrogen, and progesterone in women with leiomyomas. Fertil Sterility. 1994;61(4):617–621. doi:10.1016/S0015-0282(16)56635-7
   PubMed Web of Science ®Google Scholar
• Tsao T, C. K, Hong JH, et al. Elevation of CA 19-9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis. J Clin Lab Analysis. 2007;21(3):193–196. doi:10.1002/jcla.20168
   PubMed Web of Science ®Google Scholar
• Babacan A, Kizilaslan C, Gun I, Muhcu M, Mungen E, Atay V. CA 125 and other tumor markers in uterine leiomyomas and their association with lesion characteristics. Int J Clin Exp Med. 2014;7(4):1078–1083.
   PubMed Web of Science ®Google Scholar
• Liu CC, Ko HJ, Liu WS, et al. Neutrophil-to-lymphocyte ratio as a predictive marker of metabolic syndrome. Medicine. 2019;98(43):e17537. doi:10.1097/MD.0000000000017537
   PubMed Web of Science ®Google Scholar
• Symons LK, Miller JE, Tyryshkin K, et al. Neutrophil recruitment and function in endometriosis patients and a syngeneic murine model. FASEB J. 2020;34(1):1558–1575. doi:10.1096/fj.201902272R
   PubMed Web of Science ®Google Scholar
• Tabatabaei F, Tahernia H, Ghaedi A, et al. Diagnostic significance of neutrophil to lymphocyte ratio in endometriosis: a systematic review and meta-analysis. BMC Women’s Health. 2023;23:576. doi:10.1186/s12905-023-02692-7
   PubMed Web of Science ®Google Scholar
• Jeong MJ, Park JH, Hur SY, Kim CJ, Nam HS, Lee YS. Preoperative neutrophil-to-lymphocyte ratio as a prognostic factor in uterine sarcoma. J Clin Med. 2020;9(9):2898. doi:10.3390/jcm9092898
   PubMed Web of Science ®Google Scholar
• Chen W, Zhong S, Shan B, et al. Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications. Jovarian Res. 2020;13(1):89. doi:10.1186/s13048-020-00693-w
   PubMed Web of Science ®Google Scholar
• Wu J, Chen M, Liang C, Su W. Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer: a meta-analysis and systematic review. Oncotarget. 2017;8(8):13400–13412. doi:10.18632/oncotarget.14541
   PubMed Web of Science ®Google Scholar
• apar Y, Ulucaköy A, Sezgin C, A. E, Atalay İB, Ekşioğlu MF. Diagnostic role of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in patients with enchondroma and low-grade chondrosarcoma. Joint Dis Relat Surg. 2020;31(2):286–290. doi:10.5606/ehc.2020.73629
   PubMedGoogle Scholar
• Zhang G, Yu X, Zhu L, Fan Q, Shi H, Lang J. Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid. BMC Cancer. 2020;20(1):514. doi:10.1186/s12885-020-07003-z
   PubMed Web of Science ®Google Scholar
• Bongers SH, Chen N, van Grinsven E, et al. Kinetics of neutrophil subsets in acute, subacute, and chronic inflammation. Front Immunol. 2021;12:674079. doi:10.3389/fimmu.2021.674079
   PubMed Web of Science ®Google Scholar
• Berta DG, Kuisma H, Välimäki N, et al. Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma. Nature. 2021;596(7872):398–403. doi:10.1038/s41586-021-03747-1
   PubMed Web of Science ®Google Scholar
• Wegienka G. Are uterine leiomyoma a consequence of a chronically inflammatory immune system? Med Hypotheses. 2012;79(2):226–231. doi:10.1016/j.mehy.2012.04.046
   PubMed Web of Science ®Google Scholar
• Ciebiera M, Włodarczyk M, Wrzosek M, et al. TNF-α serum levels are elevated in women with clinically symptomatic uterine fibroids. Inter J Immuno Pharmacol. 2018;32:2058738418779461. doi:10.1177/2058738418779461
   Google Scholar
• Sevostyanova O, Lisovskaya T, Chistyakova G, et al. Proinflammatory mediators and reproductive failure in women with uterine fibroids. Gynecolog Endocrinol. 2020;36(sup1):33–35. doi:10.1080/09513590.2020.1816726
   PubMedGoogle Scholar
• Mlodawska OW, Saini P, Parker JB, et al. Epigenomic and enhancer dysregulation in uterine leiomyomas. Human Reproduction Update. 2022;28(4):518–547.
   PubMed Web of Science ®Google Scholar
• Han K, Kim SY, Kim HJ, et al. Nonspherical polyvinyl alcohol particles versus tris-acryl microspheres: randomized controlled trial comparing pain after uterine artery embolization for symptomatic fibroids. Radiology. 2021;298(2):458–465. doi:10.1148/radiol.2020201895
   PubMed Web of Science ®Google Scholar
• Çınar M, Aksoy RT, Güzel Aİ, et al. The association between clinical parameters and uterine fibroid size in patients who underwent abdominal myomectomy. J Experiment Therapeut Oncol. 2016;11(3):195–198.
   PubMedGoogle Scholar
• El Shazly AN, Soliman DR, Assar EH, Behiry EG, Gad Ahmed IAEN. Phosphate disturbance in critically ill children: incidence, associated risk factors and clinical outcomes. Ann Med Surg. 2017;21:118–123. doi:10.1016/j.amsu.2017.07.079
   PubMedGoogle Scholar